A Muth, O Ragnarsson, G Johannsson… - Journal of British …, 2015 - academic.oup.com
Background Primary aldosteronism (PA) is the most common cause of secondary hypertension. The main aims of this paper were to review outcome after surgical versus …
Hypertension is the most important modifiable cause of cardiovascular (CV) disease and all- cause mortality worldwide. Despite the positive correlations between blood pressure (BP) …
MVB Malachias - Arquivos brasileiros de cardiologia, 2016 - SciELO Brasil
On behalf of the Brazilian Society of Cardiology, Brazilian Society of Hypertension and Brazilian Society of Nephrology, I present to you the 7th Brazilian Guideline of Arterial …
K Nishimoto, SA Tomlins, R Kuick… - Proceedings of the …, 2015 - National Acad Sciences
Primary aldosteronism (PA) represents the most common cause of secondary hypertension, but little is known regarding its adrenal cellular origins. Recently, aldosterone-producing cell …
Y Ohno, M Sone, N Inagaki, T Yamasaki, O Ogawa… - …, 2018 - Am Heart Assoc
There have been several clinical studies examining the factors associated with cardiovascular disease (CVD) in patients with primary aldosteronism (PA); however, their …
There exists a great knowledge gap in terms of long-term effects of various surgical and pharmacological treatments on outcomes among primary aldosteronism (PA) patients. Using …
VC Wu, YH Hu, LK Er, RF Yen, CH Chang… - Journal of the Formosan …, 2017 - Elsevier
Background/Purpose Even though the increasing clinical recognition of primary aldosteronism (PA) as a public health issue, its heightened risk profiles and the availability …
VC Wu, SM Wang, SCJ Chueh, SY Yang, KH Huang… - Scientific reports, 2017 - nature.com
Constitutive activation of the Wnt pathway/β-catenin signaling may be important in aldosterone-producing adenoma (APA). However, significant gaps remain in our …
G Maiolino, G Rossitto, V Bisogni, M Cesari… - Journal of the …, 2017 - Am Heart Assoc
Background Current guidelines recommend use of the aldosterone‐renin ratio (ARR) for the case detection of primary aldosteronism followed by confirmatory tests to exclude false …